Compositions and methods for treating cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 1, 2016
Grant Date -
Jan 28, 2016
app pub date -
Jul 27, 2015
filing date -
Jul 25, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compositions containing one or more COX inhibitors in combination with one or more antagonists of 20-HETE (20-hydroxyeicosatetraeonic acid), and optionally a pharmaceutically acceptable excipient are provided. Preferred compositions include rofecoxib in combination with HET0016. The compositions have reduced side effects due to COX inhibitors. Methods for treating or inhibiting cancer using the disclosed compositions are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully